CHARLENE M JORDAN

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BLACKSBURG, VA NPI 1679800643

General Payments — all program years on this page

$5,400.17

Category: General Payments
Program years: PY2021–2024
Record count: 157
As of (CMS publication): 2026-01-23

Latest program year (PY2024): $2,492.12 across 65 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of payment	Amount	Records
Food and Beverage	$1,237.31	50
Long term medical supply or device loan	$999.96	12
Education	$254.85	3

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entity	Amount	Records
NOVARTIS PHARMACEUTICALS CORPORATION	$1,087.94	19
Incyte Corporation	$277.90	4
ABBVIE INC.	$230.58	6
Lilly USA, LLC	$105.86	1
Daiichi Sankyo Inc.	$78.31	3
Ipsen Biopharmaceuticals, Inc	$50.51	2
GlaxoSmithKline, LLC.	$49.15	2
Astellas Pharma US Inc	$46.82	2
BeiGene USA, Inc.	$40.79	2
Bayer HealthCare Pharmaceuticals Inc.	$37.21	2
Regeneron Healthcare Solutions, Inc.	$35.73	1
Takeda Pharmaceuticals U.S.A., Inc.	$35.69	2
Janssen Biotech, Inc.	$33.73	2
Gilead Sciences, Inc.	$31.06	1
TerSera Therapeutics LLC	$29.22	1
Alnylam Pharmaceuticals Inc.	$27.34	1
Merck Sharp & Dohme Corporation	$26.85	1
Novocure Inc.	$25.50	1
E.R. Squibb & Sons, L.L.C.	$25.43	1
Genentech USA, Inc.	$24.42	1
Genmab U.S., Inc.	$22.86	1
PFIZER INC.	$21.61	1
Karyopharm Therapeutics Inc.	$21.01	1
Celgene Corporation	$20.64	1
Alexion Pharmaceuticals, Inc.	$19.73	1
Deciphera Pharmaceuticals Inc.	$18.41	1
Spectrum Pharmaceuticals Inc.	$17.24	1
PROGENICS PHARMACEUTICALS, INC.	$17.05	1
ARRAY BIOPHARMA INC	$16.94	1
Coherus Biosciences Inc.	$16.59	1

By program year

Program year	Amount	Records
2021	$643.30	32
2022	$1,075.00	27
2023	$1,189.75	33
2024	$2,492.12	65

Records — PY2024 (65)

Record ID	Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Source
1078795496	Janssen Biotech, Inc.	$17.26	03/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1078795552	Janssen Biotech, Inc.	$16.47	09/27/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086296334	Bayer Healthcare Pharmaceuticals Inc.	$22.40	01/12/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086299170	Bayer Healthcare Pharmaceuticals Inc.	$14.81	04/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1087091828	Novartis Pharmaceuticals Corporation	$26.52	01/04/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1087091842	Novartis Pharmaceuticals Corporation	$1.84	03/21/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1087091848	Novartis Pharmaceuticals Corporation	$11.26	03/20/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1087091870	Novartis Pharmaceuticals Corporation	$18.81	08/28/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1087091872	Novartis Pharmaceuticals Corporation	$3.25	09/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1087091876	Novartis Pharmaceuticals Corporation	$83.33	08/23/2024	Long term medical supply or device loan	Undisputed	01/23/2026	View at CMS
1087091878	Novartis Pharmaceuticals Corporation	$83.33	09/27/2024	Long term medical supply or device loan	Undisputed	01/23/2026	View at CMS
1087091880	Novartis Pharmaceuticals Corporation	$83.33	01/18/2024	Long term medical supply or device loan	Undisputed	01/23/2026	View at CMS
1087091882	Novartis Pharmaceuticals Corporation	$83.33	02/16/2024	Long term medical supply or device loan	Undisputed	01/23/2026	View at CMS
1087091884	Novartis Pharmaceuticals Corporation	$83.33	03/15/2024	Long term medical supply or device loan	Undisputed	01/23/2026	View at CMS
1087091886	Novartis Pharmaceuticals Corporation	$83.33	04/18/2024	Long term medical supply or device loan	Undisputed	01/23/2026	View at CMS
1087091888	Novartis Pharmaceuticals Corporation	$83.33	05/16/2024	Long term medical supply or device loan	Undisputed	01/23/2026	View at CMS
1087091890	Novartis Pharmaceuticals Corporation	$83.33	06/13/2024	Long term medical supply or device loan	Undisputed	01/23/2026	View at CMS
1087091892	Novartis Pharmaceuticals Corporation	$83.33	07/15/2024	Long term medical supply or device loan	Undisputed	01/23/2026	View at CMS
1087091894	Novartis Pharmaceuticals Corporation	$17.56	09/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1087091896	Novartis Pharmaceuticals Corporation	$83.33	11/14/2024	Long term medical supply or device loan	Undisputed	01/23/2026	View at CMS
1087091898	Novartis Pharmaceuticals Corporation	$83.33	10/17/2024	Long term medical supply or device loan	Undisputed	01/23/2026	View at CMS
1087091904	Novartis Pharmaceuticals Corporation	$83.33	12/10/2024	Long term medical supply or device loan	Undisputed	01/23/2026	View at CMS
1087091906	Novartis Pharmaceuticals Corporation	$8.74	12/11/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1089439293	Daiichi Sankyo Inc.	$26.61	12/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1089439299	Daiichi Sankyo Inc.	$28.25	04/10/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1089439301	Daiichi Sankyo Inc.	$23.45	01/10/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1091961675	Ipsen Biopharmaceuticals, Inc	$17.98	03/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1091961677	Ipsen Biopharmaceuticals, Inc	$32.53	03/12/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1094022249	Alexion Pharmaceuticals, Inc.	$19.73	04/26/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1101086379	Celgene Corporation	$20.64	06/12/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1101235019	E.R. Squibb & Sons, L.L.C.	$25.43	07/24/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1107424700	ABBVIE INC.	$19.94	02/08/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1107424702	ABBVIE INC.	$25.54	06/01/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1107424704	ABBVIE INC.	$49.99	06/25/2024	Education	Undisputed	01/23/2026	View at CMS
1107424706	ABBVIE INC.	$105.61	07/23/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1107424708	ABBVIE INC.	$12.38	08/31/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1107424710	ABBVIE INC.	$17.12	12/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1114323020	Regeneron Healthcare Solutions, Inc.	$35.73	04/16/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1116303449	GlaxoSmithKline, LLC.	$24.76	07/31/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1116447360	GlaxoSmithKline, LLC.	$24.39	01/08/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1120853896	BeiGene USA, Inc.	$21.29	08/19/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1120853898	BeiGene USA, Inc.	$19.50	09/25/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1123334512	Novocure Inc.	$25.50	07/10/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1125841521	Alnylam Pharmaceuticals Inc.	$27.34	03/22/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1126834802	Genmab U.S., Inc.	$22.86	08/15/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1128513129	PROGENICS PHARMACEUTICALS, INC.	$17.05	04/19/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1131194856	ARRAY BIOPHARMA INC	$16.94	02/03/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1131315471	PFIZER INC.	$21.61	06/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1133149928	Genentech USA, Inc.	$24.42	02/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1133672390	Gilead Sciences, Inc.	$31.06	01/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1135582608	Lilly USA, LLC	$105.86	08/19/2024	Education	Undisputed	01/23/2026	View at CMS
1139490864	Astellas Pharma US Inc	$26.02	02/14/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1139528318	Astellas Pharma US Inc	$20.80	08/23/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1141191893	Incyte Corporation	$129.63	11/07/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1141215782	Incyte Corporation	$26.89	10/30/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1141287626	Incyte Corporation	$99.00	09/18/2024	Education	Undisputed	01/23/2026	View at CMS
1141290620	Incyte Corporation	$22.38	08/07/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1141756236	Merck Sharp & Dohme LLC	$26.85	02/12/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1144720407	TerSera Therapeutics LLC	$29.22	03/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1144977882	Takeda Pharmaceuticals U.S.A., Inc.	$16.62	05/01/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1144977884	Takeda Pharmaceuticals U.S.A., Inc.	$19.07	10/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1145538882	Karyopharm Therapeutics Inc.	$21.01	05/08/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1145877187	Deciphera Pharmaceuticals Inc.	$18.41	11/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1147275368	Coherus Biosciences Inc.	$16.59	05/15/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150656044	Spectrum Pharmaceuticals Inc.	$17.24	10/16/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS

Provenance & corrections

Dataset: CMS Open Payments — General Payments
Source: CMS Open Payments dataset (bulk file)
Publisher of source data: Centers for Medicare & Medicaid Services
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.